Clinical Trials Directory

Trials / Sponsors / Selecta Biosciences, Inc.

Selecta Biosciences, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA
Methylmalonic Acidemia (MMA)
Phase 1 / Phase 22022-12-19
CompletedA Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Thera
Chronic Gout
Phase 22019-05-07
CompletedSafety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers
Smoking Cessation
Phase 12017-05-11
CompletedMulti-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood
Gout Chronic, Hyperuricemia
Phase 22016-10-01
CompletedSafety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Level
Gout
Phase 12015-12-01
CompletedSafety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
Gout
Phase 12015-05-01
CompletedSafety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers
Smoking Cessation
Phase 12011-11-01